Oligodendrocytes wrap nerve fibres in the central nervous system with layers of specialized cell membrane to form myelin sheaths 1 . Myelin is destroyed by the immune system in multiple sclerosis, but myelin is thought to regenerate and neurological function can be recovered. In animal models of demyelinating disease, myelin is regenerated by newly generated oligodendrocytes, and remaining mature oligodendrocytes do not seem to contribute to this process [2] [3] [4] . Given the major differences in the dynamics of oligodendrocyte generation and adaptive myelination between rodents and humans 5-9 , it is not clear how well experimental animal models reflect the situation in multiple sclerosis. Here, by measuring the integration of 14 C derived from nuclear testing in genomic DNA 10 , we assess the dynamics of oligodendrocyte generation in patients with multiple sclerosis. The generation of new oligodendrocytes was increased several-fold in normal-appearing white matter in a subset of individuals with very aggressive multiple sclerosis, but not in most subjects with the disease, demonstrating an inherent potential to substantially increase oligodendrocyte generation that fails in most patients. Oligodendrocytes in shadow plaques-thinly myelinated lesions that are thought to represent remyelinated areas-were old in patients with multiple sclerosis. The absence of new oligodendrocytes in shadow plaques suggests that remyelination of lesions occurs transiently or not at all, or that myelin is regenerated by pre-existing, and not new, oligodendrocytes in multiple sclerosis. We report unexpected oligodendrocyte generation dynamics in multiple sclerosis, and this should guide the use of current, and the development of new, therapies.
. 14 C in the atmosphere is present in the form of 14 CO 2 , which is taken up by plants during photosynthesis and then enters the food chain, resulting in atmospheric 14 C levels being mirrored in the human body at any given time. When a cell duplicates its chromosomes during mitosis, it will integrate 14 C in the genomic DNA at a concentration that corresponds to that in the atmosphere and create a stable date mark for when the cell was born. Integration of 14 C in the human body can be measured with a precision of ±1.6 years 10 . By comparing the level of 14 C in genomic DNA to that in the atmosphere, it is possible to infer the age, and with mathematical modelling calculate the turnover dynamics of a cell population 5, 10, [12] [13] [14] . We used a previously established strategy to isolate mature oligodendrocyte cell nuclei to high purity by flow cytometry from human post-mortem brain tissue using antibodies to SOX10, which is expressed at all maturational stages in the oligodendrocyte lineage, and the monoclonal antibody CC1, which specifically labels the cell nuclei of myelinating oligodendrocytes 5 ( Fig. 1a , b, Extended Data Fig. 1 , Methods). We extracted genomic DNA and measured the 14 C concentration by accelerator mass spectrometry 15 . See Supplementary Table 1 for measured 14 C concentrations, associated data and patient information.
Multiple sclerosis is characterized by focal lesions, with large areas in the brain appearing grossly normal. It is, however, well-established that there is microglial activation, axonal pathology and reduction of myelin in areas referred to as normal-appearing white matter (NAWM), and this is thought to underlie some of the neurological deficits 16 . We isolated oligodendrocyte nuclei from NAWM in post-mortem tissue from patients with multiple sclerosis (n = 29) and determined the 14 C concentration in genomic DNA (Fig. 1c, d , Supplementary Table 1) . We used our previously published data on the oligodendrocyte genomic DNA 14 C concentration from healthy subjects (n = 34) 5 , which was collected and processed in parallel and identically to this study, with overlapping birth and death dates of the included subjects, as a reference to assess whether oligodendrocyte generation is altered in multiple sclerosis.
We first determined the 14 C concentration in genomic DNA of mature oligodendrocytes in subjects born before the onset of the nuclear bomb tests, which provides high sensitivity to detect cell generation at later times with highly increased atmospheric 14 C concentration, which also overlapped with the time period when the patients developed multiple sclerosis. There was no statistically significant difference in 14 C levels in genomic DNA between healthy subjects and individuals with multiple sclerosis born before the increase in atmospheric 14 C in 1955 ( Fig. 2a , P = 0.85, Mann-Whitney U-test), establishing that the disease had not affected the rate of oligodendrocyte generation in these patients.
However, several patients with multiple sclerosis born later displayed highly increased generation of oligodendrocytes (see Supplementary  Data and Supplementary Tables 2-8 ). Seven patients with multiple sclerosis had more than a threefold higher turnover of oligodendrocytes in NAWM compared to the median in healthy subjects of the corresponding age (Fig. 2b , c, Supplementary Tables 4, 5 ). There is little inter-individual variation in oligodendrocyte generation in the white matter of healthy individuals (median annual turnover in individuals >30 years of age is 0.33% (confidence interval 0.23-0.44%), Supplementary Table 5), whereas the high turnover rate in NAWM in several young patients made the turnover more heterogeneous and significantly higher in the multiple sclerosis group (median 0.58% (0.32-1.26%), P = 0.02, Mann-Whitney U-test, Supplementary Table 4 ). In the seven patients with multiple sclerosis with a more than threefold increase in oligodendrocyte generation, on average 49.9% of the oligodendrocytes in the analysed NAWM were generated after the disease onset (Fig. 2d) .
Oligodendrocyte generation and remyelination becomes less efficient with age in models of multiple sclerosis in rodents 17, 18 , raising the question as to whether this result may be related to the age of the patient. However, there was no correlation between the age at disease onset and the oligodendrocyte generation rate in the patients with multiple sclerosis (Fig. 2b , r s = −0.099, P = 0.68, Spearman correlation). Moreover,
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if the older patients born before the nuclear bomb tests during the Cold War would have had a high oligodendrocyte generation rate the first decade after disease onset, it would have left a lasting mark and would readily have been detected long after, as 14 C acts as a cumulative label. Rather than the increased level of oligodendrocyte generation in some patients being related to their age, a common factor for these individuals was that they had very aggressive disease with rapid progression to death. The time from disease onset to death was inversely correlated with the oligodendrocyte generation rate in the patients with multiple sclerosis (Fig. 2c , r s = −0.57, P = 0.0081, Spearman correlation). As tissue from all patients was collected post-mortem during the same time period, the individuals with the most aggressive disease died at the youngest age, and that is why this effect was seen in the latest born patients.
Although all patients with a highly increased oligodendrocyte generation rate had rapid disease progression, there were other patients who had similarly rapid disease progression without an increased oligodendrocyte generation rate, suggesting that the disease, or the response to it, is heterogeneous. Although the tissue appeared normal, we do not know whether these new oligodendrocytes were fully functional, and whether their generation was beneficial for the patients. Nevertheless, the marked increase in some individuals with aggressive disease demonstrates that there is an inherent potential to substantially increase oligodendrocyte generation and long-term integration in humans. A better understanding of the molecular regulation of oligodendrocyte generation, and the identification of factors that may inhibit this process or the integration of new oligodendrocytes, may aid in the development of new therapies 19 . We next carbon-dated genomic DNA of mature oligodendrocytes from shadow plaques. Shadow plaques are focal multiple sclerosis lesions in which the inflammation has subsided, and they have lower myelin density than NAWM. Remyelination of lesions in animal models of multiple sclerosis results in shadow plaques, and in patients with multiple sclerosis these have therefore been inferred to represent partly remyelinated areas, although this is difficult to establish formally in humans. It is possible that shadow plaques instead represent focal areas of thinning of myelin of surviving compromised oligodendrocytes. Shadow plaques are rare and often too small to isolate sufficient numbers of cells for carbon dating from, but we were able to collect nuclei from mature oligodendrocytes for accurate measurements from 11 patients (Fig. 3a, Supplementary Table 1 ). Shadow plaques are readily distinguished in histological sections and were identified by independent experienced neuropathologists using standard criteria (see Methods). Moreover, we analysed the pattern of eriochrome cyanine staining and proteolipid protein labelling, which verified reduced myelin in each carbon-dated shadow plaque (Extended Data Figs. 2, 3) . The 14 C concentration in oligodendrocyte nuclei from shadow plaques in patients with multiple sclerosis born before the onset of 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 Calendar year 14 C measured in genomic DNA are placed corresponding to the year of birth of the individuals. In an individual born before the onset of the increase in the atmospheric 14 C during the Cold War (orange vertical line and data point), a 14 C concentration above the atmospheric curve at the time of birth indicates cell generation after 1955. In a subject born after the peak in the atmospheric 14 C concentration (blue), a 14 C concentration lower than the atmospheric 14 C concentration at the time of birth indicates cell generation after birth. d, Carbon dating of mature oligodendrocytes from NAWM from patients with multiple sclerosis (mean ± 2 s.d., n = 29). The red line indicates the corresponding values from mature oligodendrocytes from healthy subjects born at different times (from ref. 5 ).
Letter reSeArCH the nuclear bomb tests or during the rapid increase in atmospheric 14 C concentration was lower than in white matter from healthy subjects ( Fig. 3b , P = 0.0047, Mann-Whitney U-test) and in NAWM from patients with multiple sclerosis (P = 0.011, Mann-Whitney U-test) born during the same time period. If there had been an increase in the generation of oligodendrocytes in the shadow plaques during the disease period, which in all of these patients overlapped with the period of very highly increased atmospheric 14 C levels compared to the time of birth of these individuals, they would have increased 14 C. By contrast, the 14 C level, and thus oligodendrocyte generation, was reduced in shadow plaques.
This demonstrated that the generation of new oligodendrocytes had been reduced during the disease period, and that the remaining oligodendrocytes were largely generated before the onset of the disease. We modelled how an absence of oligodendrocyte generation after disease onset would affect the 14 C level (see Supplementary Data). This closely corresponded to the measured 14 C levels in mature oligodendrocytes from the shadow plaques (P = 0.31, Mann-Whitney U-test, Fig. 3b , Extended Data Fig. 4 ). We cannot exclude the possibility that there was some integration of new oligodendrocytes in the shadow plaques, at a level below the detection by carbon dating, but we can set a firm upper limit to the proportion of oligodendrocytes in the shadow plaques that could have been generated after the disease onset to maximally 3.1 ± 1.6% (mean ± s.d.; Extended Data Fig. 5) . Thus, the integration of new oligodendrocytes was minimal in shadow plaques, which could mean that either the shadow plaques represent incompletely demyelinated lesions or that the lesions had been demyelinated and remyelinated by old oligodendrocytes.
The density of mature oligodendrocytes in the shadow plaques was similar to that in the adjacent NAWM (Fig. 3c , Extended Data Fig. 6 ; P = 0.26, paired two-tailed t-test), corroborating previous studies, which have demonstrated an unaltered or reduced number of mature oligodendrocytes in shadow plaques in humans 20, 21 . This is in contrast to animal models, in which the density of mature oligodendrocytes is highly increased in remyelinated lesions, as an independent indication that there is de novo generation of oligodendrocytes in rodents 22 . We next assessed cell proliferation by immunohistochemical detection of the proliferation marker Ki-67 combined with the oligodendrocyte marker SOX10 in shadow plaques and adjacent NAWM present in the same tissue section (Extended Data Fig. 7 ). There was no statistically significant difference in the number of proliferating cells (Ki-67
, when analysing all cell types together, between the two tissue types (shadow plaques versus NAWM, average 0.016 ± 0.024% and 0.018 ± 0.034%, Ki-67
+ of all cells, P = 0.83, paired Wilcoxon test, n = 11, Supplementary Table 9 ). However, proliferating oligodendrocyte progenitor cells (OPCs) (Ki-67 + and SOX10 + ) were much less numerous and were found in 8 out of 11 NAWM areas and in 2 out of 11 shadow plaques in the same tissue sections (Extended Data Fig. 7e , f). There were significantly fewer proliferating OPCs in shadow plaques than in NAWM (average 0.022 ± 0.067 per mm 2 and 0.049 ± 0.103 per mm 2 , P = 0.0078, paired Wilcoxon test, n = 11, Supplementary Table 9 ). This reduced generation of oligodendrocyte lineage cells, together with previous data suggesting inefficient integration of new oligodendrocytes in multiple sclerosis lesions 23, 24 , is likely to contribute to the lack of new oligodendrocytes in shadow plaques. disease duration to death have a significantly increased oligodendrocyte generation rate after the multiple sclerosis onset. Individual turnover rate calculations are sensitive to deviations in measured 14 C, especially for subjects born during the rapid increase in atmospheric 14 C, and three subjects were excluded in b-d owing to unrealistically high turnover rates from the analysis. Six additional subjects were excluded as the turnover rate could not be estimated owing to poor fit (n = 20 in b and c). The full data are given in Supplementary Table 4 . d, The total proportion of all oligodendrocytes exchanged is markedly increased in some patients with aggressive disease and short disease duration to death (n = 20). The red line indicates the proportion of oligodendrocytes that are exchanged over time in healthy adults (0.32% per year 5 ). r s , Spearman's correlation coefficient.
OPCs can differentiate directly to oligodendrocytes without proliferation 25 , and it is important to consider whether old OPCs could give rise to mature oligodendrocytes without proliferation in shadow plaques in humans. This would give the impression that the oligodendrocytes are old by 14 C analysis, although they would be newly generated. This scenario, however, can be ruled out for two reasons. First, carbon dating revealed that OPCs in NAWM of patients with multiple sclerosis are younger than the oligodendrocytes in shadow plaques (P = 0.036, Mann-Whitney U-test, Fig. 4a, b) . Thus, even if OPCs directly differentiated to mature oligodendrocytes without any proliferation, the oligodendrocytes would appear significantly younger than what we found. Second, as OPCs are approximately 20-fold less numerous than mature oligodendrocytes in the white matter of the adult human brain 5, 26 (Supplementary Table 10 ), more than four cell divisions would be required for progenitor cells to reconstitute the observed density of mature oligodendrocytes. This would result in the incorporation of 14 C at the concentration present during the disease period. We modelled this scenario (see Supplementary Data), which even with very conservative estimates would be detected as significantly different by the carbon-dating strategy (P = 0.0022, MannWhitney U-test; Supplementary Tables 11, 12 ), allowing us to exclude this possibility.
We report that oligodendrocyte generation is markedly increased in NAWM in some patients with multiple sclerosis with very aggressive disease, but unaltered in most patients, and that the integration of new oligodendrocytes is undetectable in shadow plaques. This demonstrates both a substantial potential to increase oligodendrocyte generation in the human brain and a failure of this process in focal lesions. The lack of persisting oligodendrocytes generated during the disease period in shadow plaques does not exclude the possibility that new oligodendrocytes are generated, but if so, they are very few and/or fail to survive and integrate long term.
Our results point to substantial differences between rodents and humans in the dynamics of oligodendrocyte generation in demyelinated 1920 1930 1940 1950 1960 1970 1980 1990 a, 14 C concentration in genomic DNA of oligodendrocyte nuclei isolated from shadow plaques in patients with multiple sclerosis. In patients born before the peak in the atmospheric concentration of 14 C, most data points are lower than in oligodendrocyte genomic DNA from healthy subjects (red line), indicating reduced generation (mean ± 2 s.d., n = 11). b, Significantly lower 14 C concentration in genomic DNA of oligodendrocytes in shadow plaques from patients with multiple sclerosis born before the increase in atmospheric 14 C compared to oligodendrocytes in healthy subjects (**P = 0.0047, two-tailed Mann-Whitney U-test). The 14 C concentration in genomic DNA of mature oligodendrocytes in shadow plaques is similar to the modelled 14 C concentration if there would have been no oligodendrocyte generation after the disease onset (P = 0.31, twotailed Mann-Whitney U-test) (n = 10, 6 and 6). c, The density of mature oligodendrocytes (SOX10 + NOGO-A + ) is not significantly different between shadow plaques and adjacent NAWM (P = 0.26, paired two-tailed t-test, a hypothesis test of the difference between population means for a pair of random samples) (n = 11). Mean ± s.d. (long line ± short lines) (b, c). 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 Calendar year 14 C concentration in OPCs (SOX10 + CC1 − ) in NAWM (mean ± 2 s.d., n = 18) compared to mature oligodendrocytes in healthy subjects (red line). b, The 14 C concentration in genomic DNA of OPCs in NAWM (n = 9) is significantly higher than in mature oligodendrocytes (OLs) in shadow plaques (n = 6) (mean ± s.d.,*P = 0.0360, two-tailed Mann-Whitney U-test), indicating that OPCs do not give rise to mature oligodendrocytes by direct differentiation, even without taking into account the fact that they would need to divide several times to make up for the larger number of oligodendrocytes. In the scenario in which there would be a subset of OPCs that had not divided after birth, and therefore had a very low 14 C concentration in genomic DNA, modelling demonstrates that the four cell divisions required to reconstitute the number of oligodendrocytes would result in significantly higher 14 C concentrations than measured (mean ± s.d., 4× OPCs, **P = 0.0022, two-tailed Mann-Whitney U-test).
lesions. This may reflect principal differences in how myelination is modulated in rodents and humans under physiological conditions [5] [6] [7] [8] [9] . It is also possible that animal models of multiple sclerosis may not optimally reflect the human disease and the cellular responses to it 27 . It has been well-documented that regeneration may be accomplished in diverse ways depending on the injury model. For example, pancreatic beta cells can in different situations be regenerated from progenitor cells, by beta cell duplication or by transdifferentiation 28 . If shadow plaques represent remyelinated areas in humans, our results suggest that remyelination is not carried out by new cells, but by old, spared oligodendrocytes. In line with this, a recent study has demonstrated a depletion of OPCs and increased expression of myelination genes in mature oligodendrocytes in multiple sclerosis 29 . When myelin is cleared in multiple sclerosis lesions, mature oligodendrocytes remain at approximately intact numbers, albeit stripped of their myelin 21 . Autoantibodies against myelin-associated epitopes may result in the observed selective destruction of myelin sheaths, leaving the oligodendrocyte cell body intact 21 , suggesting that remyelination may take place as long as the oligodendrocyte is not lost 30 . This may, in part, explain the known benefit of early diagnosis and aggressive treatment of multiple sclerosis to avoid the development of permanent functional impairment 31 . Our results suggest that immediate and active therapeutic interventions that inhibit the destruction of oligodendrocytes may be crucial to enable remyelination, remissions and functional recovery.
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No statistical methods were used to predetermine sample size. Sample size sufficiency was based on previous experiments from the Frisén laboratory and previous publications using the 14 C carbon dating strategy 5, 10, [12] [13] [14] . In brief, by measurement of the levels of 14 C in genomic DNA of tissue samples from subjects of different ages, we obtained information about cell age and dynamics of cell generation. The sensitivity of determining the cell age is different for each subject depending on when the subjects were born in relation to the nuclear bomb test. A subject born before 1955 will have higher sensitivity for detecting cell generation late in life, whereas a subject born after the nuclear bomb test will have higher sensitivity for detecting cell generation early in life. Hence, analysing several subjects of different ages and of different birth dates in relation to the nuclear bomb test rather than analysing several subjects of the same age provides the highest total sensitivity of the detection of cell turnover and the information of when a cell population is generated in time. Moreover, 14 C acts as a cumulative label. The number of subjects was deemed sufficient when the addition of another subject did not alter the turnover dynamics of the cell population. Randomization was not applicable in this study as the objective was to study a specific pathology process and not an intervention. The multiple sclerosis samples included were selected according to tissue and lesion type by an independent neuropathologist using standard criteria (see 'Tissue collection'), and all samples in the study were treated equally. Sex-specific differences were minimized by including a similar number of male and female patients when possible. Tissue samples were not blinded for nuclei and flow cytometry experiments. Experiments by accelerator mass spectrometry were blinded to sample identity. Patient pathology history was blinded during data collection. https://www.brainbank.nl). Characterization and identification of tissue samples were done by an independent experienced neuropathologist following standard criteria 32 . All material has been collected from donors from whom written consent for a brain autopsy and the use of the material and clinical information for research purposes had been obtained by the brain tissue banks and collaborators. Multiple sclerosis tissue samples (shadow plaques and NAWM) and associated clinical and neuropathological data were also supplied by the Multiple Sclerosis Society Tissue Bank, funded by the Multiple Sclerosis Society of Great Britain and Northern Ireland, registered charity 207495. Additional multiple sclerosis tissue samples (NAWM) were received from Cleveland Clinic, Lerner Research Institute, Cleveland, Ohio, USA with ethical permission granted by the Cleveland Clinic Institutional review board. Nuclear isolation and flow cytometry. Snap-frozen NAWM tissue samples from patients with multiple sclerosis (pre-frontal and frontal regions, classified as described previously 33, 34 ) were dissected and adjacent grey matter was removed carefully. Snap-frozen multiple sclerosis tissue sample blocks with white matter shadow plaques (classified as described previously [34] [35] [36] ) were carefully dissected to include as little adjacent NAWM as possible, before the tissue sample blocks with multiple sclerosis shadow plaques were processed for nuclei isolation and flow cytometry. Part of the tissue blocks were sectioned in 12-20-μm thick sections for immunohistochemical analyses and 25-30-μm thick sections for myelin staining. The NAWM tissue, the shadow plaque tissue and the adjacent NAWM were cut into smaller pieces and homogenized with a glass Douncer in lysis buffer as previously described 5 . Triton X-100 in the lysis solution gently permeabilizes the nuclei and together with the freezing of the tissue after the collection this enables nuclear antigen detection using antibodies. The isolated cell nuclei were then incubated with primary antibodies against SOX10 (1:250, goat, R&D Systems) and APC/CC1 (1:250, mouse-anti APC, clone CC1, Millipore/Calbiochem) in nuclei storage buffer (0.43 M (15%) sucrose, 70 mM KCl, 2 mM MgCl 2 , 10 mM Tris-HCl (pH 7.2)) for 1 h on ice. Species-specific Alexa 488-and Alexa 647-conjugated secondary antibodies (1:1,750, Molecular Probes, Invitrogen, Jackson ImmunoResearch Laboratories Inc.) were added and incubated for 1 h. Flow cytometry analyses and sorting were carried out using a BD Bioscience Influx flow cytometer, using the same gating strategy to separate single nuclei as previously described 5, 10 .
Immunohistochemistry and tissue staining. Snap-frozen 12-20-μm thick multiple sclerosis tissue sections were fixed in 2% paraformaldehyde (PFA) for 5-10 min (depending of the thickness of the section). For immunodetection of PLP, the tissue sections were delipidized in 95% ethanol for 5-10 min followed by antigen retrieval with citrate buffer (pH 6.0, Vectashield, 3300) in a steamer for 20 min. The sections were incubated in blocking solution (10% normal donkey serum with 0.15% Triton X-100) for 1 h at room temperature and then incubated at room temperature overnight in a humidified chamber with primary antibodies in 10% normal donkey serum. The following primary antibodies were used: SOX10 (goat, 1:500, R&D System), Nogo-A (rabbit, 1:500, Millipore, monoclonal antibody 11C7, 1:10,000, a gift from M. E. Schwab), PLP (rat, 1:250, gift from B. D. Trapp), Ki-67 (mouse, clone MIB-1, 1:300, DAKO), IBA1 (rabbit, 1:1,000, WAKO, goat, 1:500, Abcam), CD68 (mouse, clone KP1, 1:400, Abcam) and TMEM-119 (rabbit, 1:250, Abcam). After thorough washing, antibody staining was visualized using species-specific fluorophore-conjugated secondary antibodies (1:500, Cy3, Alexa Fluor 405, 488, 647 from Jackson ImmunoResearch). Cell nuclei were counterstained with DAPI (4′,6-diamidino-2-phenylindole, dihydrochloride, 1 μg ml
, Sigma-Aldrich) or To-PRO-3 (1:1,000, Invitrogen) by incubation for 2-5 min. Slides were mounted with ProLong Gold Antifade mounting medium (Molecular Probes, Thermo Fisher Scientific). Eriochrome cyanine staining was used for myelin staining of multiple sclerosis shadow plaque tissue blocks. All of the following steps were performed at room temperature. Snap-frozen, 25-30-μm thick sections were fixed in 2% PFA for 10 min with following PBS wash. The tissue slides were cleared in xylene for 10 min and followed by rehydration in graded ethanol solution (2 × 100%, 2 × 95%, 2 × 70%, 50%, 2 × H 2 O) for 2 min each. The slides were placed in eriochrome solution (2 ml of 10% FeCl 3 and 40 ml of 0.2% eriochrome cyanine (Sigma-Aldrich) in 0.5% aqueous H 2 SO 4 and brought to a final volume of 50 ml with dH 2 O) for 10 min, then washed in water for 1 min and differentiated with 0.5% ammonium hydroxide (NH 4 OH) for 10 s. After rinsing in water for 1 min, the slides were dehydrated in graded ethanol solution (2× H 2 O, 50%, 2 × 70%, 2 × 95%, 2 × 100%), cleared in xylene and coverslipped with mounting media. Images were acquired with Zeiss LSM880 confocal microscope with Zen2012 software or a Leica CTR6000 bright-field microscope, with LAS AF 3 software. Image processing and assembly were performed with Image J/Fiji software (version 1.47v for Mac, Java 1.6.0_65), Adobe Photoshop CS6 and Illustrator CS6 for Mac.
Quantification of oligodendrocyte cell numbers and Ki-67
+ cells. Multiple sclerosis tissue samples with a shadow plaque (characterizes and classified as described [34] [35] [36] ) and adjacent NAWM from 11 individuals were analysed. Images of the whole multiple sclerosis tissue sample section were taken with a Zeiss LSM880 confocal microscope, using Zen2012 software and a 20× Plan-Apo objective. After the image of the whole tissue section was taken, the microscope software function 'positioning' was used to image the selected sampling area frames. The respective eriochrome cyanine myelin-stained image was also used as a guide to locate shadow plaque area/areas. Sampling area frames were randomly placed in the shadow plaque area/areas and regions of adjacent NAWM of the same section. The numbers of DAPI + (cell nuclei marker), SOX10 + (oligodendrocyte lineage) and NOGO-A + (mature oligodendrocyte) cells were counted in a sampling area frame of 0.18 mm 2 (0.4251 mm × 0.4251 mm). A minimum of 12 frames per region (shadow plaque region and NAWM region) per section and individual were imaged and counted. Total number of counted cells per region was 2,100-7,400 cells. Image processing and analysis or quantification were performed using ImageJ/Fiji software (version 1.47v for Mac, Java 1.6.0_65) with customized macros for the numbers, area and fluorescence intensity 37, 38 . In brief, in each sampling area frame (0.18 mm 2 ), DAPI staining was first used to count the total number of nuclei. DAPI staining of very small cell nuclei (area pixels less than 10 or 14) were excluded owing to, for example, half of a cell captured in the image or cell debris. The digital counting of DAPI + cells was validated by manual counting in 2-3 frames in all individuals. The same region-of-interest area from DAPI + cells were then used to analyse whether the cells were positive for SOX10 and NOGO-A staining. This resulted in a DAPI + cell with an intensity of SOX10 staining and an intensity of NOGO-A staining. The baseline intensities for non-oligodendrocytes, DAPI + only, for each individual were analysed when the intensities of each cell for NOGO-A and SOX10 were plotted together (x and y axis, respectively, see below for further analysis) and also by manual visual comparison of the same sampling frame. The digital counting of SOX10 and NOGO-A staining was also compared and confirmed by manual counting of the number of cells (of SOX10 and NOGO-A staining) in the same sampling frame. Two or three frames per region per individual were manually checked. The same numbers of counting frames from shadow plaque and NAWM regions per individual were analysed. Two separate investigators were blinded to individual cases and analysed the same set of images of shadow plaque regions and NAWM regions from the 11 individuals, and the cell numbers per mm 2 (cell densities) were presented as an average cell density per region per individual (see Fig. 3c and Extended Data Fig. 6 ).
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To assess the numbers of cells with SOX10 and NOGO-A staining, a twodimensional (2D) histogram of DAPI + cells was generated with respect to SOX10 and NOGO-A staining (intensities). 2D regression was used to fit DAPI + cells only (SOX10 All parameters (amplitude, baseline, 2D centre position, 2D s.d., and rotation angle) were fitted using least-squares optimization for shadow plaque and NAWM samples (that is, to fit the distribution as close as possible to the experimental data). Two standard deviations were used to quantify the cell numbers of DAPI
) and mature oligodendrocyte (SOX10
To quantify proliferating cells (Ki-67
, images of the whole multiple sclerosis tissue sample section with shadow plaque and adjacent NAWM region were taken with a Leica TCS SP8X confocal microscope, using LAS AF software and a 20× Plan-Apo objective. The number of Ki-67 + cells and the overlap with DAPI (cell nuclei marker) and SOX10 (oligodendrocyte lineage) labelling were manually counted in the whole section (n = 11 multiple sclerosis samples and patients) using ImageJ/Fiji software. For total cell number quantification in the shadow plaque area and adjacent NAWM, Imaris-based automated quantification was used. Images of the whole multiple sclerosis tissue section were visualized in Imaris software 7.6, in which the total cell nuclei number using DAPI nuclei stain were quantified by the spot finding algorithm using the same nuclei mask size parameter across all samples with manual adjustment for fluorescence intensity threshold and quality. Minimum total counted cells per region per patient with multiple sclerosis were 20,908 cells. Quantification was repeated at least three times per sample, and the investigator was blinded to individual cases. DNA extraction. DNA extraction from sorted nuclei was performed as previously Accelerator mass spectrometry. All sample analyses performed by the accelerator mass spectrometer were sample identity blinded and carried out as previously described 5 . FACS purity correction of 14 C values. The FACS-sorted samples of oligodendrocyte nuclei contained a small fraction of non-oligodendrocyte nuclei (see Supplementary Table 1 for FACS purity). This impurity was accounted for by correcting the 14 C values so that they could accurately reflect the oligodendrocytes and was done as previously described 5 . For those cases that we did not obtain Δ 14 C values for the non-oligodendrocyte nuclei fraction the measured Δ 14 C values were instead presented. Statistical analysis and mathematical modelling. Paired t-tests were used to determine significant difference between cell numbers in tissue biopsies with NAWM and shadow plaques from patients with multiple sclerosis. D' Agostino and Pearson normality test (PRISM 7) were used to test the normality of the data. Non-parametric Mann-Whitney U-test was used to assess statistically significance difference between the measured carbon levels and individual turnover rates. Nonparametric Spearman correlation was used to correlate individual turnover rate with age at onset or disease duration in Fig. 2 . Paired non-parametric Wilcoxon test was used to determine significant difference between proliferating cells (Ki-67) and proliferating OPCs (Ki-67
in shadow plaques and adjacent NAWM present in the same tissue section. All tests were two-tailed and P < 0.05 was considered to be significant. All statistical analysis was performed in PRISM 7. Mean ± s.d. are shown unless indicated. Mathematical modelling was used to find the best turnover model that fit the measured 14 C data, and to explore and rule out theoretical scenarios of turnover. Mathematical modelling was performed in MATLAB R2016a. Details of the mathematical modelling are included in the Supplementary Data. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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Data collection
Flow cytometry data analysis and sorting were performed on BD Influx using the BD FACS™ software (BD Biosciences). Confocal images were acquired with Zeiss LSM880 confocal microscope using Zen2012 software and with Leica TCS SP8X confocal microscope, using LAS AF software. Microscope images were acquired with Leica CTR6000 bright-field microscope, using LAS AF 3 software. Nanodrop measurements were done using NanoDrop 2000/2000c Operating Software, version 1.6.
Data analysis
Image analysis, processing, assembly and counting were performed with Zen2012 software, Image J/Fiji software (version 1.47v for Mac, Java 1.6.0_65), Imaris 7.6 (Bitplane), Adobe Photoshop CS6 and Illustrator CS6 for Mac. GraphPad Prism 7 software was used for all statistical analysis. MATLAB R2016 was used for mathematical modeling. Modeling equations are given in the supplementary data and references are described of previously established models.
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All studies must disclose on these points even when the disclosure is negative.
Sample size
No statistical methods were used to predetermine sample size. Sample size sufficiency was based on previous experiments from our laboratory and previous publications using the 14C carbon dating strategy. In brief, by analysis of tissue samples from subjects of different ages using our strategy of birth dating cell nuclei by the content of nuclear bomb-test derived 14C in genomic DNA, we are able to get different information regarding cell generation and thus cellular generation dynamics. The sensitivity of determining the cell age is different for each subject depending on when the subjects was born in relation to the nuclear bomb test. A subject born before 1955 will have higher sensitivity for detecting cell generation late in life, whereas a subject born after the the nuclear bomb test will have higher sensitivity of detecting cell generation early in life. Hence, analyzing several subjects of different ages and of different birth dates in relation to the nuclear bomb test rather than analyzing several subjects of the same age will provides the highest total sensitivity of cell turnover detection and the information of when a cell population is generated in time. Moreover, 14C acts as a cumulative label. The number of subjects were sufficient when adding another subject did not change the information of the cell population's generation dynamics.
Data exclusions Internal controls and individual controls (cortical neurons) were used to control for the AMS 14C measurements. If the controls were contaminated the MS sample was excluded. This exclusion criteria was pre-established. Estimated MS patient annual turnover rate of mature oligodendrocyte in normal appearing white matter were excluded due to poor fit based on residuals. Patient with residual over 1 or unrealistic turnover rate were excluded as stated in Supplementary Table 4 . It was pre-established to exclude data points based on poor fit. The exclusion of unrealistic values were not pre-established.
Replication
Due to tissue limitation, replication of the experiment from the same tissue block of the subject was not possible for carbon dating experiment as the whole tissue sample were used per measurement. However, an internal control from the same subject was used to replicate the strategy (AMS measurement). Moreover, 40 samples were used verifying the reproducibility of the flow cytometry and carbon dating experiments.
Randomization Randomization was not applicable in this study as the objective was to study a specific pathology process and not an intervention. The MS samples included were selected according to tissue and lesion type by independent neuropathologist using standard criteria (see method section) and all samples in the study were treated equally. Sex-specific differences were minimized by including similar number of male and female patient when possible.
Blinding
Tissue samples were not blinded in nuclei and flow cytometry experiments. Experiments by AMS of the following samples were blinded to sample identity. Patient pathology history was blinded during whole data collection.
Materials & experimental systems
Policy information about availability of materials n/a Involved in the study The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation This is described in Methods under "Nuclear isolation and flow cytometry" section.
Instrument
BD Influx
